Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Treasury Shares: 2019-2023

Historic Treasury Shares for ADC Therapeutics (ADCT) over the last 3 years, with Sep 2023 value amounting to -$541,000.

  • ADC Therapeutics' Treasury Shares fell 435.64% to -$541,000 in Q3 2023 from the same period last year, while for Sep 2023 it was -$541,000, marking a year-over-year decrease of 435.64%. This contributed to the annual value of $679,000 for FY2022, which is 430.47% up from last year.
  • Per ADC Therapeutics' latest filing, its Treasury Shares stood at -$541,000 for Q3 2023, which was up 2.87% from -$557,000 recorded in Q2 2023.
  • In the past 5 years, ADC Therapeutics' Treasury Shares registered a high of $679,000 during Q4 2022, and its lowest value of -$645,000 during Q1 2023.
  • Over the past 3 years, ADC Therapeutics' median Treasury Shares value was -$119,000 (recorded in 2022), while the average stood at -$140,545.
  • As far as peak fluctuations go, ADC Therapeutics' Treasury Shares plummeted by 3,349,900.00% in 2021, and later spiked by 430.47% in 2022.
  • Quarterly analysis of 5 years shows ADC Therapeutics' Treasury Shares stood at $100,000 in 2019, then reached -$4 in 2020, then plummeted by 3,324,900.00% to $128,000 in 2021, then soared by 430.47% to $679,000 in 2022, then tumbled by 435.64% to -$541,000 in 2023.
  • Its Treasury Shares stands at -$541,000 for Q3 2023, versus -$557,000 for Q2 2023 and -$645,000 for Q1 2023.